Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...

Dad John Story said the introduction of "Lyla's Law" – routine testing for those showing symptoms – would be a "lasting ...

LITTLE Lyla Story should have been celebrating her third Christmas with her family. Instead, she passed away in May last year ...

For parents of kids with Type 1 diabetes (T1D) — an autoimmune condition in which the pancreas stops producing insulin — that ...

Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete and virologic response compared with entecavir (Baraclude), a ...

Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those ...

New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and ...

India is not only the “diabetes capital” of the world but is also fast emerging as the “diabetic retinopathy capital,” experts warned, while attribut ...

BENGALURU: Early gestational diabetes mellitus (GDM) is emerging as a growing concern among pregnant women in India, with doctors warning that delayed detection ...

Rising metabolic disorders in India are fuelled by genetic predisposition, rapid lifestyle changes and hidden risk factors.

An American Heart Association presidential advisory in 2023 introduced a new term: cardiovascular-kidney-metabolic syndrome.